Australia's largest stock trading and investment forum Australia's #1 stock forum

OPT opthea limited

0.00%

60.0¢

Ann: Security Class Reinstatement to Quotation- OPTOB, page-319

First 319 Last

Share
Profile

Follow
Diamondtoe

6 Posts.

22/10/24

16:20

Post #: 76245254
Share

Originally posted by FreeFromStyle: ↑

Mid April 2025 will be when the probability wave collapses for all of us. Until then, any predictions are just speculation.

We just have to manage our risk tolerance and gauge the likelihood of Phase 3 results replicating the promising outcomes from Phase 2b, particularly with the efficacy endpoint. From a statistical standpoint, comparisons between the Phase 2b results and the masked data from Phase 3, especially given the large sample size, strongly suggest that we should see the results replicated and/or improved.

.

If Phase 3 is successful, we obviously will see significant gainz... but wait there is more - potential bonuses or extra returns.

A successful outcome in Phase 3 would also pave the way for advancing into DME Phase 3 trials and the co-formulation with VEGF-A treatments. As I understand it, Opthea’s treatment currently requires a second injection and 30 minutes wait to allow stabilization eye pressure, since the fluid of multiple injections can increase pressure in the aqueous humor of the eye. Co-formulation, I expect, could reduce this to just one injection, making sozinibercept ubiquitous in the treatment of nAMD—a market valued at USD $15 billion per year.

Expand

Thank you FreeFromStyle.
Hopefully we will receive some good news!

OPT Price at posting: 81.0¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

First 319 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 60.0¢		Change 0.000(0.00%)		Mkt cap ! $738.7M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Ann: Security Class Reinstatement to Quotation- OPTOB, page-319

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News

Featured News

Ann: Security Class Reinstatement to Quotation- OPTOB, page-319

Top Stories

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News

Featured News